A Major Step Forward in the Decades-Long Search for an HIV…

A Major Step Forward in the Decades-Long Search for an HIV Vaccine For nearly four decades, scientists have been chasing one of the hardest problems in vaccine science: how to protect against HIV, a virus so genetically diverse that traditional vaccine approaches simply don't work against it. A new study published in Nature, June 2026, by researchers at Scripps Research Institute and collaborators, may represent genuine progress. The core problem with HIV vaccines are: HIV mutates so rapidly and varies so much between strains that a vaccine targeting one version often fails against another. However, scientists have long known that a small number of HIV-infected individuals naturally develop what are called broadly neutralising antibodies, bnAbs, capable of recognising and neutralising many different HIV strains at once. The challenge has been getting a vaccine to reliably trigger the human immune system to produce these same broadly protective antibodies. This approach is called germline-targeting, essentially priming rare, specific immune cells